Price T Rowe Associates Inc Incyte Corp Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Incyte Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 225,112 shares of INCY stock, worth $18.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

225,112

Previous 643,656 65.03%

Holding current value

$18.4 Million

Previous $36.7 Million 62.78%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $21.4 Million - $26.7 Million	-418,544 Reduced 65.03%	225,112 $13.6 Million
Q1 2024 May 15, 2024	SELL	$56.55 - $66.59 $14 Million - $16.4 Million	-246,850 Reduced 27.72%	643,656 $36.7 Million
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $8.33 Million - $10.2 Million	-159,652 Reduced 15.2%	890,506 $55.9 Million
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $8.41 Million - $9.6 Million	-145,595 Reduced 12.18%	1,050,158 $60.7 Million
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $37.9 Million - $47 Million	-622,594 Reduced 34.24%	1,195,753 $74.4 Million
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $7.16 Million - $8.77 Million	-101,942 Reduced 5.31%	1,818,347 $131 Million
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $26 Million - $32.5 Million	-386,583 Reduced 16.76%	1,920,289 $154 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $72.8 Million - $91.1 Million	-1,099,310 Reduced 32.27%	2,306,872 $154 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $85.1 Million - $107 Million	-1,286,023 Reduced 27.41%	3,406,182 $259 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $170 Million - $206 Million	-2,579,483 Reduced 35.47%	4,692,205 $373 Million
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $737 Million - $863 Million	-11,638,526 Reduced 61.55%	7,271,688 $534 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $663 Million - $812 Million	-9,660,276 Reduced 33.81%	18,910,214 $1.3 Billion
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $119 Million - $130 Million	-1,488,332 Reduced 4.95%	28,570,490 $2.4 Billion
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $193 Million - $255 Million	-2,535,860 Reduced 7.78%	30,058,822 $2.44 Billion
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $2.63 Billion - $3.18 Billion	32,594,682 New	32,594,682 $2.84 Billion

Others Institutions Holding INCY

# of Institutions

629

Shares Held

198M

Call Options Held

763K

Put Options Held

476K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $18.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Incyte Corp Transaction History